Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • CleanTech • A.I. (& Big Data) • Blockchain (& Cryptos) • Analytics • Payments • Aerospace (& Defense) • Mobility |
Stages | Pre-Seed, Seed, Early Stage |
Investing | United States • Canada |
Investment Range | $10,000 - $100,000 |
Investment Sweet Spot | $25,000 |
ScienceVest is a venture capital firm based in San Francisco, CA, USA that specializes in investments in science and frontier-tech companies. They focus on early-stage funding, primarily in Pre-Seed, Seed, and Early Stage ventures, with investment amounts ranging from $10,000 to $100,000 and a sweet spot of approximately $25,000 for each investment. ScienceVest targets companies that have the potential to impact over a million lives and are raising their first institutional capital with sub-$5M valuations. Their investment strategy is aligned with addressing the key metrics from the UN Sustainable Development Goals. ScienceVest is particularly interested in companies that leverage converging fields, such as synthetic biology combined with AI, and they look for core technology breakthroughs in frontier fields including senolytics, quantum computing, space, robotics, AI, synthetic biology, and genomics. They do not invest in companies whose products and services do not support the achievement of the UN Sustainable Development Goals. Their portfolio includes diverse industries such as BioTech, CleanTech, A.I. and Big Data, Blockchain, Analytics, Payments, Aerospace, Defense, and Mobility. Specific examples from their portfolio involve investments in companies like Avro Lifescience (Biotechnology), Advano (Batteries/Materials), Greensight Agronomics (Hardware/Drones/GreenTech), Calyx (Sensors/Bacteriophages), and Filecoin (Blockchain/Storage). ScienceVest approaches investments with a high conviction, aiming to be the first money-in to support transformative companies.
We invest in science and frontier-tech companies with the potential to impact 1 Million or more lives. Companies raising first institutional capital, sub-$5M valuation, with go-to-markets addressing key metrics from the UN Sustainable Development Goals.